Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter
- 16 June 2003
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 89 (4), 771-777
- https://doi.org/10.1002/jcb.10567
Abstract
Receptor activator of NF‐κB ligand (RANKL) has been identified as requisite for osteoclastogenesis. To elucidate the molecular mechanism that conducts its catabolic action on bone, the effect of 1α,25 dihydroxyvitamin D3 (1α,25(OH)2D3) on osteoclastogenesis and RANKL mRNA expression was examined by coculture, RT‐PCR and nuclear run‐on studies. By accelerating the transcription rate of the RANKL gene in SaOS2 osteoblastic cells, 1α,25(OH)2D3 enhanced in vitro osteoclast formation from peripheral monocytes. Cloning and characterization of the 5′‐flanking region of the human RANKL gene revealed that the basic promoter comprises inverted TATA‐ and CAAT‐boxes flanked by RUNX2 binding sites. Both electrophoresis mobility shift assay (EMSA) and transfection studies demonstrated that 1α,25(OH)2D3 activated human RANKL promoter through vitamin D responsive elements (VDRE) located at −1584/−1570 by binding VDR and RXRα heterodimers in a ligand‐dependent manner. The results provide direct evidence that 1α,25(OH)2D3 augments osteoclastogenesis by transactivating the human RANKL gene in osteoblastic cells through VDRE. J. Cell. Biochem. 89: 771–777, 2003.Keywords
This publication has 29 references indexed in Scilit:
- Epigenetic control of mouse receptor activator of NF-κB ligand gene expressionBiochemical and Biophysical Research Communications, 2002
- Vitamin D Hormone Inhibits Osteoclastogenesis In Vivo by Decreasing the Pool of Osteoclast Precursors in Bone MarrowJournal of Bone and Mineral Research, 2002
- Vitamin D3 Augments Osteoclastogenesis via Vitamin D-Responsive Element of Mouse RANKL Gene PromoterBiochemical and Biophysical Research Communications, 2002
- Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritisArthritis & Rheumatism, 2000
- STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-κB Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid HormoneJournal of Biological Chemistry, 1999
- Characterization of the Intracellular Domain of Receptor Activator of NF-κB (RANK)Published by Elsevier BV ,1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D- responsive elements of the osteocalcin and osteopontin genesMolecular Endocrinology, 1996
- Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitroBiochemical and Biophysical Research Communications, 1991
- Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitroJournal of Endocrinology, 1985